Internal Opportunities

Institute for Public Health
Letter of Intent due 4/3/20

ICTS COVID-19 Research Funding Program
Applications due 5/11/20

McDonnell Academy RFA Infectious Diseases and COVID-19:  Addressing Challenges to Public Health and Society Through Global Collaboration
Applications due 6/01/2020

NIH Director’s Emergency Early Independence Awards (RFA-RM-20-021)​ (WUSTL Key required)
Internal Selection deadline is 7/7/20. Applications due to NIH 9/4/20

  • Early Independence Awards from CARES Act funding that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics

Data.org Inclusive Growth and Recovery Challenge (WUSTL Key required)
Internal Selection deadline is 6/8/2020. Applications are due 7/17/20

  • Data.org, in partnership with the Mastercard Center for Inclusive Growth and The Rockefeller Foundation, invites applications to its Inclusive Growth and Recovery Challenge seeking breakthrough ideas that harness the power of data science to help people and communities thrive especially in the wake of COVID-19’s economic impact. Up to 10 awards with a combined total of up to $10 million may be made. Eligibility is unrestricted

Opportunities for Current NIH Funded Researchers (Competitive Revisions & Supplements)

NIAID/NIGMS Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-AI-20-030)
Applications accepted 4/6/20 – 4/8/20

  • NIAID is interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.
  • NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.

Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (NOT-GM-20-027)
Applications accepted by 5/4/20

  • NIGMS will accept applications for Competitive Revisions to active U24 awards for eligible organizations to rapidly provide pilot or supplementary funds to researchers studying the development of predictive models for the spread of SARS-CoV-2 and outcomes of possible COVID-19 public health intervention measures in order to accelerate such research.

NHGRI Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-HG-20-030)
Applications accepted 4/1/20 – 5/15/20

  • NHGRI is interested are genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Funds may be used for the collection of samples from human cohorts of individuals with COVID-19 symptoms or evidence of SARS-CoV-2 infection or controls, and/or development of novel model systems to expose animals and cells to SARS-CoV-2.

NHLBI Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757)
Applications accepted on rolling basis until 5/15/20

  • NHLBI encourages the submission of applications for Administrative Supplements and Competitive Revisions to active NHLBI grants to support research on SARS-CoV-2 and heart, lung, and blood COVID-19 disease. Or particular interest are studies that take advantage of human research or unique model systems to study the consequences of SARS-CoV-2 infection.

NLM Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-LM-20-010)
Applications accepted until 6/1/20

  • NLM is encouraging the submission of applications for administrative supplements to active NLM R01 grants to address the following research areas of interest: Methods for mining clinical data that can be used to identify or predict presence of COVID-19 in biomedical phenotype data, or other relevant topics such as discovery of risks for infection by SARS-Cov-2 viruses, use of standard terminologies for these viruses in federated health data sets. Additionally,  public health surveillance methods that mine genomic, viromic, health data, environmental data and/or data from other pertinent sources such as social media, to identify spread and impact of SARS-Cov-2.

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-DC-20-004)
Applications will be accepted on a rolling basis from 4/7/20 – 6/1/20

  • NIDCD is encouraging the submission of applications for supplements to active NIDCD grants to address the pathology, prevention, diagnosis, sequelae, or treatment of COVID-19 directly related to NIDCD’s mission areas of hearing, balance, taste, smell, voice, speech and language.

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK’s Mission (NOT-DK-20-020)
Notice expires on 6/2/20

  • For this funding opportunity announcement, NIDDK is interested in the submission of applications for Competitive Revisions to active grants to elucidate if COVID-19 might provoke or exacerbate noncommunicable gastrointestinal, liver, kidney/urological and metabolic/endocrine diseases in people with HIV (PWH) or worsen the consequences of viral hepatitis coinfection.

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (NOT-DK-20-018)
Applications accepted until 6/1/20

  • NIDDK is particularly interested in the submission of applications for Competitive Revisions to active grants  focusing on the direct action of the virus on kidney, gastrointestinal tract function, and the endocrine/metabolic system, and the collection of biosamples that will inform the understanding of renal, gastrointestinal, and endocrine/metabolic sequelae of viral infection. Pilot clinical studies (observational and interventional) that support the understanding or treatment of COVID-19-related diseases within the mission of the NIDDK are also of interest. NIDDK will only consider applications that propose projects that may lead to rapid translation and impact in the COVID-19 emergency to be responsive to this NOSI.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Applications accepted on a rolling basis from 4/15/20 through 6/19/20

  • NIH is encouraging the submission of innovative applications for Emergency Competitive Revisions to active Common Fund grants and cooperative agreements. Innovation may be technological or conceptual. Any relevant area of innovative research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics.

Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-043)
Applications accepted on a rolling basis from 4/14/20 through 6/25/20

  • NCI encourages small businesses with NCI-funded active SBIR/STTR awards with promising technologies that have a strong potential to be adapted/repurposed for use as a prophylactic, therapeutic or diagnostic tool for SARS-CoV-2 (COVID-19) to submit applications to PA-18-935, Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional).

Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-042)
Applications accepted on a rolling basis from 4/14/20 through 6/25/20

  • NCI encourages the submission of applications for urgent competitive revisions or administrative supplements of existing grants to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer.

NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)(NOT-AI-20-034)
Applications will be accepted on a rolling basis until 3/25/21

  • National Institute of Allergy and Infectious Diseases (NIAID) is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19.  Applications must be submitted to PA-20-135 which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.

Other HHS Funding Opportunities

Biomedical Advanced Research and Development Authority (BARDA) BAA Amendment (BAA-18-100-SOL-00003_Amendment_13)
Applications accepted until 4/30/20 at 3:30 PM Central

  • BARDA is soliciting applications for topics specifically relating to COVID-19, including diagnostic assays, point-of care-diagnostic assays, vaccines, therapeutics, prophylaxis, respiratory protective devises, and ventilators.

AHRQ Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

  • Agency for Healthcare Research and Quality is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations. AHRQ will encourage multimethod, rapid-cycle research with the ability to produce and disseminate findings as early as 6 months.

Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (NOT-HS-20-008)

  • AHRQ intends to publish a new funding opportunity announcement using the R01 mechanism to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19.  This Notice is being provided to allow potential applicants sufficient time to develop responsive applications

Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) (RFA-HS-20-003)
Applications due 6/15/20

  • This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic.

Department of Defense Sponsored Funding Opportunities

Defense Logistics Agency’s Technology Accelerator OTA Program
The white paper submission period closes May 4, 2020, at 1:00 EDT.

  • DLA seeks novel solutions to combat COVID-19. Specifically, the DoD suffers from an increasing demand for Personal Protective Equipment (“PPE”) for individuals who perform critical national security functions. Of particular concern are N95 masks, which are primarily produced overseas.

NOTICE OF INTENT: MTEC National Emergency Telecritical Care Network (NETCCN) Project

  • MTEC will seek proposals for cloud-based, low-resource, stand-alone health information management systems for the creation and coordination of flexible and extendable “virtual critical care wards” based on existing technology in mobile communication and real-time data collection and reporting. MTEC expects to make up to six (6) initial awards to qualified teams to accomplish the initial enhanced development effort.

MTEC Development of Treatments for COVID-19 Technologies
Enhanced White Papers are due by 4/8/2020 at 11:00 AM Central

  • The Medical Technology Enterprise Consortium (MTEC) is seeking proposals focused on the development of COVID-19 treatments with potential application to the prevention of infection and therapeutics that can be administered in a non-hospital environment. Military relevance is a critical component of this solicitation.

Wearable Diagnostic for Detection of COVID-19 Infection (MTEC-20-12-COVID-19_Diagnostics)
White papers due May 13, 2020

  • The goal of this RPP is to develop a wearable diagnostic capability for the pre-/very earlysymptomatic detection of COVID-19 infection.

Newton Award for Transformative Ideas During the COVID-19 Pandemic (BRO-20-NEWTON)
Open to receive applications continuously until 4:00 p.m. Eastern Time (ET), 15 May 2020

  • This award will be presented to a single investigator or team of up to two investigators that develops a “transformative idea” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD and the nation at large. Proposals should aim to produce novel conceptual frameworks or theory-based approaches that present disruptive ways of thinking about fundamental scientific problems that have evaded resolution, propose new, paradigm-shifting scientific directions, and/or address fundamental and important questions that are argued to be undervalued by the scientific community.

Interoperable Medical Automated Systems (iMAS) Technology and Gap Assessment
Applications are due 6/18/20

  • Request for Project Proposals (RPP) that aims to help develop a research prototype for the ability to telemonitor and capture research data for the following research areas: COVID-19 wards, emergency rooms/trauma rooms (ERs/TRs), and neurological patients. This capability will help develop the Department of Defense’s (DoD’s) interoperable Medical Automated Systems (iMAS) program.

Department of State

Countering Corruption Amid COVID-19 (WUSTL Key required) 
Internal Selections deadline is 5/21/2020. (Sponsor deadline is 6/12/20)​

  • The U.S. Department of State, Bureau of Democracy, Human Rights and Labor (DRL) announces an open competition for organizations interested in submitting applications in support of the goal of combatting corruption arising in response to the COVID-19 pandemic.

Environmental Protection Agency

State Environmental Justice Cooperative Agreement Program (SEJCA)/ COVID-19 Projects
Applications due June 30

  • EPA is giving a special consideration to those applications aimed at addressing the impacts of the COVID-19 pandemic on urban and rural low income and minority communities. EPA anticipates making five awards in amounts of up to $200,000 per award for a two-year project period. EPA encourages applicants to develop innovative plans and processes to conduct effective outreach to underserved communities in the midst of social-distancing and local stay-at-home orders, especially in places where internet access may not be readily available to all residents.

IARPA

IARPA COVID-19 Seedling Research Topics
Applications are due 7/7/20

  • IARPA seeks high-risk/high-payoff research programs for these technology needs relevant to the COVID-19 pandemic: detection and sensing; supply chain management and integrity; geo-spatio-temporal monitoring and mapping, with privacy protection; information reliability and collaboration tools; modeling, simulation, and predictive analytics

Agriculture and Food Research Initiative (AFRI)

STOP Spillover
Internal Selection Deadline 5/12/20

  • USAID’s STOP Spillover program aims to reduce the spillover of emerging zoonotic viruses from wildlife to people and reduce the amplification and spread of zoonotic viruses in people after they have spilled over from wildlife. USAID plans to fund 1 award up to $100,000,000.

DOD Peer Reviewed Medical Research Program–Investigator-Initiated Research Award (for Emerging Viral Diseases and Respiratory Health)
Pre-applications are due by 5/28/20

  • The US Army Medical Research and Development Command (USAMRDC) and the Congressionally Directed Medical Research Programs (CDMRP) are pleased to announce four additional dedicated Program Announcements (PAs) for the FY20 Peer-Reviewed Medical Research Program (PRMRP) that are focused on COVID-19 and SARS-COV-2. These special COVID-19 PRMRP PAs will invest approximately $75M of the FY20 PRMRP $360M appropriation in COVID-19 related research.

DOD Peer Reviewed Medical Research Program–Technology/Therapeutic Development Award (for Emerging Viral Diseases and Respiratory Health)
Pre-applications are due by 5/28/20

  • The US Army Medical Research and Development Command (USAMRDC) and the Congressionally Directed Medical Research Programs (CDMRP) are pleased to announce four additional dedicated Program Announcements (PAs) for the FY20 Peer-Reviewed Medical Research Program (PRMRP) that are focused on COVID-19 and SARS-COV-2. These special COVID-19 PRMRP PAs will invest approximately $75M of the FY20 PRMRP $360M appropriation in COVID-19 related research.

xTech COVID-19 Ventilator Challenge
Submissions are due May 31.

  • The Department of the Army invites applications to its xTech COVID-19 Ventilator Challenge to develop a low-cost, readily manufacturable emergency ventilator to quickly augment ventilator capacity during the COVID-19 pandemic. Multiple awards with a combined total of up to $1 million may be made. Eligibility is unrestricted.

Rapid Response to Novel Coronavirus (SARS-CoV-2) Impacts Across Food and Agricultural Systems (A1711)
Applications accepted by 6/5/20

  • The COVID-19 pandemic is impacting the nation’s food and agricultural systems. Currently, data is needed to reliably guide decision-making that are supported by scientific evidence. This program area priority addresses the need to develop and deploy rapid, reliable, and readily adoptable strategies across the food and agriculture enterprise in response to the COVID-19 pandemic.

Veterans Health Administration

VHA Innovation Ecosystem and precisionFDA COVID-19 Risk Factor Modeling Challenge
Challenge ends 7/3/2020

  • The Veterans Health Administration (VHA) Innovation Ecosystem and Food and Drug Administration (FDA) call on the scientific and analytics community to develop and evaluate computational models to predict COVID-19 related health outcomes in Veterans.

Non-Federal Opportunities

AHA Rapid Response Grant: COVID-19 and its Cardiovascular Impact
Applications accepted until 4/6/20 at 5 PM Central

  • The American Heart Association is accepting applications for an unprecedented rapid response call for cardiovascular/cerebrovascular research proposals to address the growing crisis of the COVID-19 pandemic. The Association is offering fast-tracked research grants for short-term projects that can turn around results within 9-12 months to better understand the diagnosis, prevention, treatment and clinical management of COVID-19 as it relates to heart and brain health.

LifeArc COVID-19 Fund
Applications accepted until 4/6/20

  • LifeArc is calling for applications for therapeutics that could be repurposed or repositioned for use in COVID-19 patients. The primary purpose is to accelerate availability of treatments for patients and it is therefore expected that applicants will already have material available for testing and a plan for rapid scale up of clinical material.  Priority will be given to projects that have a clear path and availability for patients in a 6 -12 month time frame.

Children, Screens and COVID-19
Proposals may be accepted until 5/11/20

  • Children and Screens is interested in studies that assess the positive and negative impact the role that screens play in families’ lives as a result of the COVID pandemic. For example, during the pandemic screens are relied upon for distance learning and are the sole means of maintaining social connections. How well are they performing in this regard? What approaches have proven effective and for which populations? Conversely, relaxed limits on screens may increase the prevalence of compulsive use, anxiety, depression and other untoward effects previously attributed to digital media. This challenge grant ($100K) is intended to leverage and augment existing cohort studies.

AXA Research Fund: Mitigating Risk in the Wake of the COVID-19 Pandemic
Application will be accepted on a rolling basis until 5/7/20

  • This Research Fund is opening a call for projects in areas of protecting vulnerable populations from epidemics and catastrophes, including COVID-19, improving data collection and quality in health, understanding the effects of confinement and social distancing, early warning and preparedness and preserving the environment and our health. There is a limit of one application per department.

American Psychological FoundationAPF COVID-19 Rapid Response Grant
Applications are accepted until 5/1/20

  • Up to $20,000 to support psychological research in response to the COVID-19 pandemic.

Elrha – RESEARCH TO SUPPORT COVID-19 RESPONSE IN HUMANITARIAN SETTINGS
Applications accepted in rounds until 5/3/20

  • This Call focuses on identified priorities related to the current COVID-19 outbreak in humanitarian settings* in low and middle-income countries (LMICs). Proposals will be eligible for research that targets:
    • Refugees or IDPs in camps or urban humanitarian settings, or conflict-affected people in humanitarian settings in LMICs
    • Health systems and health care workers supporting the COVID-19 response in humanitarian settings in LMICs.

Harrington Discovery Institute
Applications due April 30, 2020

  • Harrington Discovery Institutes seeks to accelerate programs in its current portfolio that may target Coronavirus and its clinical ramifications, particularly on the lungs and heart. This entails advancing treatments that may enter clinical trials right away. They also seek to aggressively seek broad spectrum antivirals that may avert the next viral pandemic.

C3.ai DTI COVID-19 Research Award
Proposals must be submitted before 5/1/20 but submissions before 4/15/20 will be reviewed for early potential award notification.

  • PIs must be researchers from the C3.ai DTI consortium member institutions, but Washington University faculty can serve as Co-Investigators. This call for proposals focuses on understanding and mitigating the spread of COVID-19, improving the ability of the public health and medical establishment to respond, and minimizing the impact of this disease on society. The interests of C3.ai DTI are in the use of AI/ML, data analytics, cloud computing, and change management to mitigate the course and impact of the disease.

Internet Society Foundation
Applications accepted until 5/17/20

  • We recognize the importance that the Internet plays during this uncertain time, serving as a lifeline that enables children to continue learning; families and friends to stay connected; and vital public health information to keep circulating. The Foundation is committed to working with organizations that take known Internet-based technical solutions and apply them to COVID-19 responses or are pivoting from their “regular” activities to create new projects or reworked technical solutions that respond to the pandemic. Grants of $250,000 to $500,000 USD will be awarded for projects lasting up to 12 months.

Johnson and Johnson Drug Resistant Tuberculosis Lifeline QuickFire Challenge
Deadline is 5/19/2020

  • J&J is seeking innovative proposals for creative, easy-to-implement ideas with the aim to solve for the continuity of DR-TB services during the pandemic and after, since health systems will take time to return to efficiency.  Submissions should address continuity of DR-TB care for patients in high-burden countries (e.g., India, Indonesia, Philippines, South Africa, Ukraine).  Up to five innovators with the best ideas, technologies, or potential solutions could be awarded grant funding from a total of $250,000*

United States – India Science and Technology Endowment Fund COVID-19 Ignition Grants
Applications due on  5/15/2020

  • The United States–India Science & Technology Endowment Fund (USISTEF) seeks to support and foster joint applied R&D to generate public good through the commercialization of technology developed through sustained partnerships between U.S. and Indian researchers and entrepreneurs. USISTEF encourages out-of-the-box, innovative ideas from the community to address the COVID-19 challenge. Ignition Grant proposals should address proof-of-concept based on sound science and engineering research, potential for commercial viability and practicality of the idea/innovation/technology.

Alkermes COVID-19 Relief Fund to Support Innovative Programs Helping Vulnerable Patient Communities 
Deadline is 05/20/2020

  • Alkermes Inspiration Grants program will provide up to a total of $500,000 in grants to assist nonprofit organizations in their work to urgently address COVID-19-related needs for people living with addiction, serious mental illness or cancer.

American Diabetes Association COVID-19 and Diabetes Research Call for Applications.
The COVID-19 and Diabetes Research Awards expedited application deadline will be 5pm ET on May 22, 2020 for July 1, 2020 funding.

  • The American Diabetes Association (ADA) is requesting applications (see RFA) for research focused on the impact of diabetes on COVID-19 and the impact of COVID-19 on diabetes and its complications. The goal of this RFA is to use a rapid application and review process to identify at least 10 grants of up to $100,000/each in this area and of high scientific merit for immediate funding.

COVID-19 Targeted PFA
Full applications will be due Tuesday, May 26, 2020, by 5:00 p.m. ET

  • In order to respond to the COVID-19 pandemic, PCORI is issuing a new research funding announcement with an accelerated timeline to support innovative, high-impact studies that fit clearly within our core mission of patient-engaged and patient-centered comparative clinical effectiveness research. The objectives of this announcement are to (1) strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and (2) provide evidence to inform clinical and public health responses, decision making, and planning.

Facebook Research – Economic Impact of Digital Technologies Request for Proposals
Applications accepted until 5/20/20

  • When growth is challenged by economic contraction or other disruptive circumstances (such as COVID-19), digital technologies may offer businesses the means to quickly adjust their practices, enabling them to minimize adverse impacts and remain resilient. Facebook is interested in supporting projects that address the economic consequences and implications of developing digital technologies for small businesses.

Pfizer COVID-19 Competitive Grant Program
Applications accepted by 5/22/20

  • Pfizer requests proposals in two caterories: Category A: Independent Medical Education Grants; and Category B: Quality & Process Improvement Grants.

Russell Sage Foundation Research Grants       
Letters of inquiry accepted for 5/21/20 deadline

  • Because of the effects of COVID-19 on all facets of American life, the Russell Sage Foundation is changing its immediate priorities for letters of inquiry for the May 21, 2020, deadline. For this deadline, RSF will only consider LOIs that satisfy at least one of the following criteria: The research is so timely and time-sensitive that the project must start before April 1, 2021; or the research analyzes social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States.

The Rheumatology Research Foundation
Letter of Intent deadline is 6/1/20

  • The Rheumatology Research Foundation is issuing a notice of special interest (NOSI) to highlight the availability of funds for projects exploring the relationships between rheumatic and musculoskeletal diseases and SARS-CoV-2, the virus that causes COVID-19

Health Effects Institute (HEI) Air Pollution, COVID-19, and Human Health
Mandatory letter of intent (LOI) due June 8th.

  • HEI solicits applications for research on novel and important aspects of the intersection of exposure to air pollution and COVID-19 health outcomes: (1) Accountability research: What are the effects of the unprecedented interventions taken to control the COVID-19 pandemic on emissions, air pollution, and human health? (2) Susceptibility factors: Are individuals/populations who have been chronically or acutely exposed to higher levels of air pollution at greater risk of mortality from COVID-19 compared to those exposed to lower levels of air pollution? Do the effects differ by race/ethnicity or by measures of socioeconomic status?

Emergency Medical Foundation
Proposals are due 6/5/20

  • The Emergency Medicine Foundation is awarding funding of up to $100,000 in new research grants on emergency medicine areas related to COVID-19. 

Booz Allen Foundation: Innovation Grant
Applications accepted until 6/5/20

  • The Booz Allen Foundation has established a $1 million Innovation Fund to help nonprofits, entrepreneurs, thought leaders, innovators at colleges and universities, and startups and small businesses harness the power of data, technology, and diverse intellectual capital to improve COVID-19 relief efforts and make a difference. The Foundation is specifically targeting solutions and projects that will build lasting community resilience through protecting vulnerable populations and frontline workers or providing for the safe return to work. Nonprofits can apply for grants of up to $100,000.

American Lung Association COVID-19 Action Initiative
Deadline to submit an application is May 30, 2020 (11:59 PM ET)

  • ALA is soliciting proposals for COVID-19 and Emerging Respiratory Viruses Awards ($100,000 per year for up to two years). They are looking for outstanding investigators who can advance our knowledge of COVID-19 and other novel respiratory viruses with pandemic potential.

Social Science Research Council (SSRC)
Applications are due 6/1/20

  • The Social Science Research Council (SSRC), as part of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that address the social, economic, cultural, psychological, and political impact of Covid-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects.

Spencer Foundation
Application on a rolling basis until 6/8

  • Spencer Foundation is issuing a call for proposals for a COVID-19 Related Special Grant Cycle to support education research projects that will contribute to understanding the rapid shifts in education in this time of crisis and change.

St. Louis CARES Humanitarian Response Program
RFPs submissions are due by 5 p.m., 6/17/20

Approximately $9.5 million will be allocated through the St. Louis CARES Humanitarian Response Program. The goal of the program is to fund program and services that support the needs of County residents suffering from the effects of the COVID-19 public health emergency in order to promote recovery for the region and mitigate the effects of the pandemic. A full list of eligibility requirements can be found here, along with the link to the application.

Pfizer Vaccine Preventable Diseases – COVID-19
Applications are due 6/17/20

  • The intent of this Request for Proposal (RFP) is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. We are particularly interested in supporting research in the following areas:
    • Understand impact of COVID on communities, spectrum of disease in communities, and level of herd immunity
    • Postmortem Analysis of deceased persons with known or suspected COVID-19

Social Data Research Fellowships
Applications are due 6/16/20

  • This grant opportunity’s primary emphasis is related to social media and the 2020 elections, however applications that investigate the impact of the coronavirus pandemic as it intersects with the core themes outlined in the grant description are particularly encouraged. For example, explorations of policy debates, news, or disinformation circulated via social media on topics relevant to the 2020 US elections and amplified by circumstances related to Covid-19–such as vote-by-mail debates, health care policy, Covid-19 disinformation campaigns related to the election, and so on–are welcome. Grants are up to $50,000.

American Thoracic Society and Glaxso Smith Kline Research Grant in COVID-19
Applications due 6/23/20

  • Assistant Professors conducting research directly related to COVID-19 are encouraged to apply. The focus of this research grant is proposals that have a high likelihood to advance the understanding of the pathobiology and clinical implications of COVID-19.

Emergency Response for the Health Care System Innovation Challenge
Phase 1 deadline is 6/12/20

  • Can you create a digital tool supporting the health care system (including but not limited to providers, government, and public health and community organizations) during a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?

Emergency Response for the General Public Innovation Challenge
Phase 1 deadline is 6/12/20

  • Can you build a health technology tool to support the needs of individuals affected by a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?

Microsoft AI for Health COVID-19 Grant Form
Grant applications will be accepted until June 15th, 2020 or until further notice.

  • Given the urgency of the COVID-19 crisis, we are accepting requests in the AI for Health program for COVID-19 grant proposals from nonprofits, academia, and governments. This is a focused effort for COVID-19 grant requests only.  This grant program provides Azure cloud and High-Performance Computing capabilities. 

MIT Solve’s 2020 Global Challenges
Deadline to submit a solution is 6/18/20

  • Solve is also seeking solutions that focus on preventative and mitigation measures that strengthen access to affordable primary healthcare systems, enhance disease surveillance systems, and improve healthcare supply chains.

The Urban Institute – From COVID-19 Response to Equitable Recovery: A Call for Research and Action to Boost Workers’ Economic Security and Mobility
The deadline to respond to both the RFP and the RFI is 11:59 pm ET, June 29, 2020.

  • To achieve these objectives, we are issuing both a Request for Proposals (RFP) and a Request for Information (RFI) to identify and accelerate innovative solutions—including programs, policies, and practices—that not only provide immediate economic relief to struggling workers and those who are out of work, but also create pathways for greater economic security and upward mobility in the long term. The RFP is designed for those with research projects in need of funding, while the RFI is designed for those who have identified promising, scalable practices in need of additional support and/or research and evaluation.

SMDM COVID-19 Decision Modeling Grant
Applications are due 6/30/20

The Society for Medical Decision Making (SMDM) is leading a collaboration to offer the COVID Decision Modeling Initiative (CDMI), which will support the development of decision models to inform the urgent needs of decision makers responding to the Covid-19 pandemic

Special Call for COVID-19 Related Projects Focused on the Federal Nutrition Assistance Programs
Applications are due 7/1/20

  • Healthy Eating Research, a national program of the Robert Wood Johnson Foundation, has a limited amount of rapid-response research funds available to commission: 1) issue briefs/ commentaries or papers/research reviews and; 2) small studies to explore the impact of the coronavirus pandemic on nutrition and diet quality, food security, and related health consequences for children and families

The COVID-19 Detect & Protect Challenge​
Submissions close on 06/30/20 at 12:00 AM PT

  • A panel of judges will review and select the top 10 open source solutions on a rolling basis through 2020. Winners will receive global recognition and variety of awards for their contribution to society and humankind. Using the UNDP’s vast global network and resources from all supporting partners, we’ll work with the winning creators on the best way to transfer the knowledge to those who need it most. This challenge has three priority actions: (1) Design replicable, low-cost tools to aid in coronavirus detection; (2) Flatten the curve in communities with preventive solutions ; (3) Reduce the disease’s impact on economies of these vulnerable areas 

Amazon Web Services Diagnostic Development Initiative (AWS DDI)
Applications accepted until 6/30/20

  • The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.